MAFFEI, Rossana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.586
AS - Asia 3.650
EU - Europa 3.409
SA - Sud America 434
AF - Africa 87
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 1
Totale 16.205
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.435
GB - Regno Unito 1.034
SG - Singapore 965
CN - Cina 809
HK - Hong Kong 795
IT - Italia 733
VN - Vietnam 413
SE - Svezia 369
DE - Germania 337
BR - Brasile 325
BD - Bangladesh 205
FI - Finlandia 200
RU - Federazione Russa 166
UA - Ucraina 135
FR - Francia 123
TR - Turchia 98
CA - Canada 86
IN - India 72
KR - Corea 61
BG - Bulgaria 51
ID - Indonesia 49
NL - Olanda 44
ES - Italia 40
AU - Australia 38
IE - Irlanda 31
AR - Argentina 29
JP - Giappone 28
ZA - Sudafrica 27
BE - Belgio 26
IQ - Iraq 24
MX - Messico 24
PL - Polonia 23
CL - Cile 21
AE - Emirati Arabi Uniti 19
CZ - Repubblica Ceca 19
PK - Pakistan 17
MA - Marocco 16
PH - Filippine 15
VE - Venezuela 14
EC - Ecuador 13
UZ - Uzbekistan 13
AT - Austria 11
CO - Colombia 11
RO - Romania 11
MY - Malesia 10
CH - Svizzera 9
DK - Danimarca 9
JM - Giamaica 9
JO - Giordania 9
KE - Kenya 9
CR - Costa Rica 8
LT - Lituania 8
PY - Paraguay 7
AZ - Azerbaigian 6
DZ - Algeria 6
EG - Egitto 6
ET - Etiopia 6
SA - Arabia Saudita 6
BZ - Belize 5
DO - Repubblica Dominicana 5
PE - Perù 5
TW - Taiwan 5
BO - Bolivia 4
GR - Grecia 4
PR - Porto Rico 4
SN - Senegal 4
TN - Tunisia 4
AL - Albania 3
BY - Bielorussia 3
CY - Cipro 3
HN - Honduras 3
HR - Croazia 3
IL - Israele 3
IR - Iran 3
KZ - Kazakistan 3
QA - Qatar 3
RS - Serbia 3
UY - Uruguay 3
AM - Armenia 2
AO - Angola 2
BH - Bahrain 2
GT - Guatemala 2
GY - Guiana 2
HU - Ungheria 2
KG - Kirghizistan 2
MD - Moldavia 2
NG - Nigeria 2
NP - Nepal 2
PT - Portogallo 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
CI - Costa d'Avorio 1
EE - Estonia 1
GA - Gabon 1
KW - Kuwait 1
Totale 16.194
Salva come PNG Salva come JPEG
Città #
Ashburn 818
Ann Arbor 792
Hong Kong 791
Fairfield 784
Southend 733
Santa Clara 637
Singapore 575
Woodbridge 469
Houston 417
Chandler 414
Seattle 313
San Jose 275
Cambridge 272
Wilmington 246
Nyköping 243
Jacksonville 215
Hefei 199
Dearborn 196
Los Angeles 163
Chicago 157
Beijing 153
Helsinki 150
London 146
Modena 145
New York 127
Ho Chi Minh City 122
Council Bluffs 114
Hanoi 98
Milan 88
Munich 71
The Dalles 68
Salt Lake City 62
San Diego 61
Seoul 59
Fremont 57
Princeton 55
Lauterbourg 51
Sofia 51
Eugene 46
Izmir 45
Moscow 45
Buffalo 41
Dallas 37
Rome 36
Bologna 35
Bremen 35
Jakarta 35
Tampa 33
Dublin 31
Frankfurt am Main 28
Orem 28
Atlanta 26
Brussels 26
Columbus 26
Shanghai 25
São Paulo 25
Elk Grove Village 24
Phoenix 24
Redwood City 23
Boardman 22
Melbourne 22
Toronto 21
Miami 20
Warsaw 20
Des Moines 19
Tokyo 19
Da Nang 18
Lancaster 18
Montreal 17
Brooklyn 16
Chennai 15
Haiphong 15
Dong Ket 14
Falls Church 14
Brno 13
Denver 13
Tashkent 13
Vancouver 13
Miano 12
Amsterdam 11
Dulles 11
Jinan 11
Naples 11
Reggio Emilia 11
Rio de Janeiro 11
Ankara 10
Baghdad 10
Bari 10
Boston 10
Guangzhou 10
Johannesburg 10
Kent 10
Madrid 10
Ninh Bình 10
Perugia 10
Turku 10
Kilburn 9
Ottawa 9
Poplar 9
San Francisco 9
Totale 11.607
Salva come PNG Salva come JPEG
Nome #
Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features. 828
Monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation 598
Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor 439
SVILUPPO DI IPOGAMMAGLOBULINEMIA IN PAZIENTI TRATTATI CON IMATINIB PER LEUCEMIA MIELOIDE CRONICA O TUMORI STROMALI GASTROINTESTINALI 420
The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli. 390
Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia 371
Mucorales-specific T cells in patients with hematologic malignancies 367
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 367
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 361
Selective inhibition of PI3Kγ affects survival and proliferation of chronic lymphocytic leukemia B cells 356
Gene expression profiling of acute promyelocytic leukaemia identifies two subtypes mainly associated with Flt3 mutational status 344
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide 343
Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis 331
Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF. 328
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile on leukemic cells. 327
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 326
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor 326
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 320
Increased expression of angiopoietin-2 characterizes early B-cell chronic lymphocytic leukemia with poor prognosis 314
Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome. 310
ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia 310
Angiopoietin-2 expression in B-cell chronic lymphocytic leukemia: association with clinical outcome and immunoglobulin heavy-chain mutational status 309
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 298
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia 297
Immunomodulatory effect of ibrutinib: Reducing the barrier against fungal infections 297
Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement 294
Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia. 294
Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study 292
Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib 284
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 284
Immunoglobulin mutational status detected through single-round amplification of partial VH region, represents a good prognostic marker for the clinical outcome in chronic lymphocytic leukemia 280
Strikingly homologous immunoglobulin gene rearrangements and poor outcome inV(H)3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status 277
BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia 277
The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells 274
INTERACTION BETWEEN ENDOTHELIUM AND CHRONIC LYMPHOCYTIC LEUKEMIA B-CELLS RESCUES FROM APOPTOSIS AND MODULATES GENE EXPRESSION PROFILE OF LEUKEMIC CELLS 274
Lenalidomide in chronic lymphocytic leukemia: The present and future in the era of tyrosine kinase inhibitors 270
Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia 266
Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: Results from an Italian multicentre study 265
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 263
Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia via Kynurenine/Aryl Hydrocarbon Receptor-Mediated MCL1 Modulation 251
Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines 250
Circulating endothelial cells in patients with chronic lymphocytic leukemia: clinical-prognostic and biologic significance. 244
Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone. 241
HOXA homeogene cluster interruption and dysregulation of HOAX9 in the blast crisis of Philadelphia chromosome-positive chronic myeloid leukemia. 236
Overexpression of CD49d in trisomy 12 chronic lymphocytic leukemia patients is mediated by IRF4 through induction of IKAROS 225
MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia 200
IGHD3-3 fails to behave as unfavourable prognostic marker in chronic lymphocytic leukaemia. 198
Casein kinase 1: A new tale of chronic lymphocytic leukemia (CLL) microenvironment 181
Vorinostat interferes with Wnt and NF-kappaB pathways in the M-07e cell line. 172
Casein kinase 1: A new tale of chronic lymphocytic leukemia (CLL) microenvironment 171
Performance trade-offs of different rake receivers 161
Feasibility of autologous peripheral blood stem cell mobilization and harvest in adult patients with FLT3-mutated acute myeloid leukemia receiving chemotherapy combined with midostaurin: a single-center experience 155
NOX-A12: Mobilizing CLL away from home 142
Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study 122
The dynamic functions of IRF4 in B cell malignancies 108
Optical genome mapping reveals multiple apoptotic and cell-cycle pathway aberrations in B-cell prolymphocytic leukemia: a report of three cases 28
GENOMIC SCREENING OF PRIMARY REFRACTORY ACUTE MYELOID LEUKEMIA WITHOUT TP53 ALTERATIONS BY OPTICAL GENOME MAPPING (OGM) 25
OPTICAL GENOME MAPPING IDENTIFIES MULTIPLE STRUCTURAL VARIATION AND CATASTROPHIC REARRANGEMENTS IN B-CELL PROLYMPHOCYTIC LEUKEMIA 14
Identification of 4 autophagy-related genetic variants as risk factors for chronic lymphocytic leukemia 10
XPO1 mutations identify early-stage CLL characterized by shorter time to first treatment and enhanced BCR signalling 9
Totale 16.314
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.317
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.317
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.057 64 134 93 46 29 82 53 53 97 84 215 107
2022/20231.247 128 156 103 114 168 164 15 145 134 12 53 55
2023/2024800 28 36 51 85 149 68 86 110 15 24 63 85
2024/20252.728 82 49 29 194 409 354 180 135 610 129 217 340
2025/20265.551 337 703 324 594 871 326 613 219 464 451 323 326
2026/2027115 115 0 0 0 0 0 0 0 0 0 0 0
Totale 16.314